| Date | Title | Description |
| 08.07.2026 | Respiro Diagnostics secures £1M to advance lung diagnostics | Respiro Diagnostics, a UK-based startup developing breath-based diagnostics for lung diseases, has raised £1 million in a pre-seed funding round led by Zinc Venture Capital and SFC Capital. The round also included participation from Amadeus... |
| 06.07.2026 | Patent cliff fuels Novartis’ $1.5bn swoop for London biotech | Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiri... |
| 26.06.2026 | Base Editing Maps Human Embryo Master Switch: NANOG Controls First Cell Fates | By Chase Fiorini
Published: Jun 26 2026, 3:29 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 24.06.2026 | IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine | IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.
Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapso... |
| 02.06.2026 | IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transfor... | IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, has successfully brought its Series A to over $53 million (£40 million... |
| 30.03.2026 | CWOW 2026: Cambridge’s life sciences showcase expands to Oxford & London | Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time.
The Cambridge-Oxford-London corridor is widely regarded as one of th... |
| 25.01.2026 | London's King's Cross: A Global Powerhouse Emerges | London's King's Cross has transformed into a global innovation and retail powerhouse. Once a neglected area, it now thrives as a leading tech and life sciences hub, attracting major investment and creating high-value jobs. Retail sales show... |
| 20.01.2026 | Kings Cross spinout district could create 20,000 new jobs | The innovation district around Kings Cross and Euston has the potential to grow into the UK’s version of Kendall Square, writes Professor Geraint Rees
A smiling Oscar Murphy, 28, was all over the news this week. Oscar had become the first p... |
| 19.01.2026 | Дайджест новостей о здоровье за прошедшую неделю | Учёные обнаружили огромное количество микропластика в городском воздухе
Исследователи из Института земной среды Китайской академии наук обнаружили, что в атмосфере крупных городов содержится значительно больше микропластика и нанопластика, ... |
| 13.01.2026 | PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics | , a rapidly emerging leader in AI-enabled cardiac diagnostics, announced the closing of its seed funding round, led by Innovation Ulster Limited, with participation from The Mortara Group and The Francis Crick Institute. The investment will... |
| 13.01.2026 | PulseAI Raises in Seed Funding | PulseAI, a Belfast, UK-based company which specializes in AI-enabled cardiac diagnostics, raised an undisclosed amount in Seed funding.
The round was led by Innovation Ulster Limited, with participation from The Mortara Group and The Franci... |
| 12.01.2026 | PulseAI: Seed Funding Secured To Advance AI-Driven ECG Diagnostics | PulseAI announced it has closed a seed funding round to expand deployment of its AI-enabled electrocardiogram (ECG) diagnostics platform and progress toward U.S. FDA 510(k) clearance, positioning the company to commercialize clinical decisi... |
| 28.12.2025 | Как древняя чума изменила человечество 5000 лет назад | У историков, изучающих болезни, возникла проблема. При исследовании образцов ДНК древнего человека генетики обнаружили гены, принадлежащие бактерии чумы Yersinia pestis, и это означало, что её эпидемия бушевала в Евразии пять тысяч лет наза... |
| 10.09.2025 | Merck to scrap London drug research centre | Merck to scrap London drug research centre
By ReutersSeptember 10, 20254:49 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Merck logo is seen in this illustration taken March 26, 2025. REUTERS/... |
| 22.07.2025 | Magentic raises $5.5M to cut costs in tariff-impacted supply chains with AI | Magentic, an AI agent platform that identifies savings across global manufacturing supply chains, has closed a $5.5 million funding round to fuel team expansion and growth.
Supplier compliance “leaks” are a widespread issue, with 90 per cen... |
| 17.07.2025 | Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease | Using this method means the embryo has DNA from three people — from the mother’s egg, the father’s sperm and the donor’s mitochondria — and it required a 2016 U.K. law change to approve it. It is also allowed in Australia but not in many ot... |
| 17.04.2025 | London’s Skills Bootcamps: A Pathway to Economic Resurgence | London is on the brink of a skills revolution. The city’s latest initiative, the Skills Bootcamps, is a beacon of hope for both workers and businesses. With a £27 million funding boost from the Department for Education, these bootcamps are ... |
| 17.04.2025 | City Hall skills bootcamps to receive £27m funding boost | City Hall is set to receive a funding boost of £27m for a skills bootcamp programme for Londoners, Sir Sadiq Khan has announced.
The mayor of London has welcomed the funding from the Department for Education (DfE) which represents a 25 per ... |
| 15.04.2025 | RevitaLash® Cosmetics Announces Road to $10 Million Goal in Support of Breast Cancer Initiatives | VENTURA, Calif., April 15, 2025 /PRNewswire/ -- RevitaLash® Cosmetics, globally recognized for its innovative lash, brow, and hair beautification products, is deepening its commitment to the fight against breast cancer with its new Road to ... |
| 13.11.2024 | Trace Neuroscience: A New Dawn in Genomic Medicine for ALS | In the realm of biopharmaceuticals, a new player has emerged, armed with ambition and a hefty $101 million in Series A funding. Trace Neuroscience is on a mission to reshape the landscape of genomic medicine, particularly for those grapplin... |
| 13.11.2024 | Trace Neuroscience: $101 Million (Series A) Raised To Expand Genomic Medicine Platform | Trace Neuroscience – a biopharmaceutical company expanding the promise of genomic medicine for people living with neurodegenerative diseases – announced its launch with a $101 million Series A funding led by Third Rock Ventures, with partic... |
| 21.10.2024 | Siloton Raises £860K in Seed Funding | Siloton, a Bristol, UK-based health technology startup, raised £860K in Seed funding.
Backers included Evenlode Foundation alongside members of the Southeast Angels, the Francis Crick Institute, and other experienced angel investors. They w... |
| 01.10.2024 | Frost & Sullivan co-published Recombinant Type III Triple-Helix Collagen Whitepaper with Everon Healthcare | SHANGHAI, Oct. 1, 2024 /PRNewswire/ -- Frost & Sullivan and Everon Healthcare have conducted extensive investigation across the recombinant collagen Industry and co-published the "Recombinant Type III Triple-Helix Collagen Whitepap... |
| 31.08.2024 | KQ Labs now accepting applications for its 7th cohort | KQ Labs, based at the Francis Crick Institute, is now accepting applications for its 7th cohort, starting January 2025. They're looking for early-stage UK-based start-ups working at the intersection of data and biomedical science. Their alu... |
| 18.03.2024 | British Land and Royal London ink joint venture for former Meta HQ in Euston | British Land has sold off half of its stake in one of London’s most notable office buildings six months after its famous former tenant upped and left.
Announced today, asset manager Royal London will take a 50 per cent stake in the Euston-b... |
| 26.10.2023 | MICA: a multi-omics method to predict gene regulatory networks in early human embryos | Introduction
After the fusion of the oocyte and sperm, the zygote undergoes a series of cell divisions until it forms a blastocyst before implantation into the uterus. A human blastocyst is formed of a fluid-filled cavity and ∼200 cells tha... |
| 17.01.2023 | Why I invited investors into my lab: Adendra Therapeutics co-founder Caetano Reis e Sousa in conversation with The Francis Crick Institute | In December 2021, Apple Tree Partners (ATP), a leader in life sciences venture capital, announced the launch of Adendra Therapeutics Ltd, a spin-out of immunology research by Crick Principal Group Leader Caetano Reis e Sousa and his team. O... |
| 17.01.2023 | Why I invited investors into my lab: Adendra Therapeutics co-founder Caetano Reis e Sousa in conversation with The Francis Crick Institute | In December 2021, Apple Tree Partners (ATP), a leader in life sciences venture capital, announced the launch of Adendra Therapeutics Ltd, a spin-out of immunology research by Crick Principal Group Leader Caetano Reis e Sousa and his team. O... |
| 09.05.2022 | Scientists Discover Genetic Cause Of Lupus, Findings May Help Research On Long Covid. | Molecular structure of toll-like receptor 7 (TLR7) FROM: "Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations" GENTILE ET AL. 2015 |
| 21.03.2022 | Medical Research Council announces plans to halve carbon footprint by 2030 | MRC announces its environmental sustainability programme to achieve net zero by 2040, as part of the UKRI sustainability strategy, with a 50% reduction by 2030.
This comprehensive programme will focus on the Medical Research Council’s (MRC)... |
| 07.12.2021 | ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A | Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute
First UK-based ATP portfolio company
NEW YORK and LONDON, December 7, 2021—ATP (Apple Tree Partners), a leader in life sciences venture ca... |
| 07.12.2021 | ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A | Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs accelerator programme | 10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and coaching as part of the KQ Labs accelerator programme, run by the Francis Crick Institute and funded by the m... |
| 01.11.2021 | KQ Labs data driven health accelerator announces its first exit, as Glamorous AI is acquired by X-Chem Inc | KQ Labs, a programme delivered by the Francis Crick Institute and funded by LifeArc, is proud to announce its first exit as Glamorous AI, a company that was part of KQ Labs’ third cohort, has been acquired by X-Chem, the US based global lea... |
| 14.07.2021 | Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc | London, UK. July 14, 2021: Novartis UK has today announced the selected companies for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data-driven health accelerator of the Francis Crick Institute, and LifeAr... |
| 17.05.2021 | KQ Labs opens applications for health start-ups for its annual accelerator programme | KQ Labs opens applications for early stage data-driven health start-ups for its fourth annual accelerator programme KQ Labs, a programme delivered by the Francis Crick Institute and funded by LifeArc, is now open for applications. Early- st... |
| 21.04.2021 | Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care | London, UK: Novartis UK has launched the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data-driven health accelerator of the Francis Crick Institute, and LifeArc, the charity helping to turn promising science ... |
| 09.03.2021 | KQ Labs announces the graduation of its third cohort in a highly successful Demo Day event | KQ Labs, an accelerator programme for start-up companies with high growth potential in the area of data-driven health, run out of the Francis Crick Institute and funded by LifeArc, hosted its Demo Day on 3 March to an invited audience of in... |
| 06.02.2021 | How the UK's Covid-19 vaccines chief bucked the rules to get it to the front of the queue | Kate Bingham volunteering for the Novavax COVID-19 vaccine trial.
Kirsty O'Connor/PA via Getty Images
Kate Bingham paused her career in venture capital to head up the United Kingdom's Covid-19 vaccine effort.
The UK has leapt ahead in the v... |
| 03.02.2021 | How the UK’s COVID-19 vaccines chief — a VC — bucked government rules and propelled the country to the front of the West’s vaccine-supply queue | Kate Bingham volunteering for the Novavax COVID-19 vaccine trial. Kirsty O’Connor/PA via Getty Images
Kate Bingham paused her career in venture capital to head up the UK’s COVID-19 vaccine effort.
The UK has leapt ahead in the vaccine race,... |
| 07.12.2020 | How Cloud Computing Can Open Doors for the Scientific and Academic Communities | Some of the most transformational technologies are those that not only solve a problem, but also dramatically change an entire field of study or industry. Jake Schofield and Labstep believe they are doing just that. Their cloud-based techno... |
| 23.11.2020 | KQ Labs Accelerator welcomes 10 innovative start-ups | London, UK – KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick Institute and now funded by LifeArc, has selected 10 new start-ups for its third cohort.
Following a highly successful second cohort, KQ... |
| 16.11.2020 | Myricx Pharma Launches with £4.5M (AU$8.2M) Financing to Progress its Novel NMT inhibitors in Cancer | Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer, today unveiled an initial £4.5 million (AU$8.2 million) in seed fi... |
| 06.07.2020 | KQ Labs opens accelerator programme and announces LifeArc as a strategic partner | KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies are invited to apply via www.kqlabs.com.
Following a highly successful second cohort, KQ Labs, an accelerator programme for s... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion
30-06-2020
PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly c... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion | PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million... |
| 01.05.2020 | How the UK life sciences industry is rising to the challenge of Covid-19 by Kate Bingham | Crisis is the mother of invention and Covid-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The UK life sciences industry is rising to the challe... |
| 15.11.2019 | King’s Cross is London’s Smartest Startups Tech Hub. Here’s What You Need to Know | 20 shares
Share
Tweet
Pin
LinkedIn
Once the ugly duckling of North London, King’s Cross has become a startup hub to rival any other: startups and tech giants alike are flocking to the area to do business.
King’s Cross: A New Global Kn... |
| 17.06.2019 | UCL Technology Fund Showcase 2019 | We would also like to thank our wonderful guest speakers for taking the time to showcase their innovation. |
| 01.05.2016 | The Genome-Editing Technology That Could Change Everything | This post originally appeared on Uncubed.
Earlier this year, Science magazine featured three independent studies describing the use of a revolutionary new genome editing technique to treat an adult mouse suffering from Duchenne muscular dys... |
| 01.02.2016 | UK government agency approves editing genes in human embryos | A team of scientists in London on Monday received the first government approval in the world to edit the genomes of human embryos for research purposes, opening a new front in genetics research.
The lead researcher, Kathy Niakan of the Fran... |
| 09.10.2015 | The public must speak up about gene editing – beyond embryo modification | The public must speak up about gene editing – beyond embryo modification
09-10-2015
Lara Marks (University of Cambridge Department of History and Philosophy of Science) and Silvia Camporesi (King's College London) discuss the genetic modifi... |
| 13.12.2012 | International collaboration with Babraham researchers reveals how cell membranes reassemble | International collaboration with Babraham researchers reveals how cell membranes reassemble
13-12-2012
An international collaboration between researchers at the Babraham Institute, Cancer Research UK’s London Research Institute, Imperial Co... |
| - | KQ Labs Opens Applications | KQ Labs opens applications for early-stage data-driven health start-ups for its third annual accelerator programme and announces LifeArc as a strategic partner
KQ Labs is now accepting applications for its third cohort of companies. Early ... |
| - | How the UK's COVID-19 vaccines chief — a VC — bucked government rules and propelled the country to the front of the West's vaccine-supply queue | Kate Bingham volunteering for the Novavax COVID-19 vaccine trial. Kirsty O'Connor/PA via Getty Images
Kate Bingham paused her career in venture capital to head up the UK's COVID-19 vaccine effort.
The UK has leapt ahead in the vaccine race,... |
